PUBLISHER: Grand View Research | PRODUCT CODE: 1321425
PUBLISHER: Grand View Research | PRODUCT CODE: 1321425
The global peripheral vascular stents market size is expected to reach USD 2.97 billion by 2030, growing at 7.4% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. The market's growth can be attributed to the increasing prevalence of peripheral vascular diseases (PVDs). According to the American Heart Association (AHA) and their Heart Disease and Stroke Statistics - 2022 Update, cardiovascular disease (CVD) was the primary cause of approximately 19.05 million deaths worldwide in 2020. In addition, cerebrovascular diseases were responsible for around 7.08 million deaths globally during the same year. These alarming statistics highlight the significant burden of cardiac diseases and underscore the need for effective interventions such as peripheral vascular stents.
The market growth is further propelled by technological advancements and the continued approval of new products, supported by partnerships and collaborations among key industry players. For instance, Cordis, a renowned cardiovascular technology company, obtained approval from the United States Food and Drug Administration (FDA) in March 2022 for the S.M.A.R.T. RADIANZ Vascular Stent System. This self-expanding stent is specifically designed for radial peripheral procedures. The recently approved BRITE TIP RADIANZ Guiding Sheath and SABERX RADIANZ PTA Catheter complement this system. These innovative solutions optimize radial access, deliver remarkable outcomes, and enhance patient satisfaction.